Healthcare provider profile · identity verified

James F Doris, MD

Family Practice · PHOENIX, AZ · NPI 1033101001

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	439	149
Atorvastatin Calcium	Atorvastatin Calcium	424	158
Amlodipine Besylate	Amlodipine Besylate	325	118
Metformin Hcl	Metformin Hcl	300	110
Rosuvastatin Calcium	Rosuvastatin Calcium	286	109
Losartan Potassium	Losartan Potassium	251	97
Lisinopril	Lisinopril	232	89
Metoprolol Succinate	Metoprolol Succinate	199	72
Gabapentin	Gabapentin	168	62
Pantoprazole Sodium	Pantoprazole Sodium	152	63
Tamsulosin Hcl	Tamsulosin Hcl	143	53
Omeprazole	Omeprazole	131	50
Sertraline Hcl	Sertraline Hcl	125	45
Hydrochlorothiazide	Hydrochlorothiazide	111	42
Metoprolol Tartrate	Metoprolol Tartrate	105	40
Albuterol Sulfate Hfa	Albuterol Sulfate	97	40
Simvastatin	Simvastatin	96	30
Escitalopram Oxalate	Escitalopram Oxalate	85	40
Valsartan	Valsartan	82	31
Montelukast Sodium	Montelukast Sodium	79	31
Ozempic	Semaglutide	71	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	70	27
Alendronate Sodium	Alendronate Sodium	67	25
Trazodone Hcl	Trazodone Hcl	66	19
Allopurinol	Allopurinol	64	26
Glipizide	Glipizide	64	23
Pravastatin Sodium	Pravastatin Sodium	64	22
Eliquis	Apixaban	60	18
Furosemide	Furosemide	59	25
Atenolol	Atenolol	58	17
Ezetimibe	Ezetimibe	55	16
Famotidine	Famotidine	53	22
Duloxetine Hcl	Duloxetine Hcl	52	13
Azithromycin	Azithromycin	51	49
Carvedilol	Carvedilol	51	23
Celecoxib	Celecoxib	49	17
Citalopram Hbr	Citalopram Hydrobromide	49	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	17
Meloxicam	Meloxicam	45	19
Prednisone	Prednisone	44	36
Fluoxetine Hcl	Fluoxetine Hcl	43	12
Bupropion Xl	Bupropion Hcl	42	19
Clopidogrel	Clopidogrel Bisulfate	42	17
Buspirone Hcl	Buspirone Hcl	41	13
Tramadol Hcl	Tramadol Hcl	40	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	39	11
Mirtazapine	Mirtazapine	38	suppressed
Synthroid	Levothyroxine Sodium	35	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	14
Estradiol	Estradiol	31	14
Irbesartan	Irbesartan	30	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	27
Fenofibrate	Fenofibrate	28	11
Hydralazine Hcl	Hydralazine Hcl	28	14
Ipratropium Bromide	Ipratropium Bromide	28	13
Jardiance	Empagliflozin	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Calcitriol	Calcitriol	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Finasteride	Finasteride	23	suppressed
Potassium Chloride	Potassium Chloride	23	suppressed
Ramipril	Ramipril	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	18
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	22	11
Paroxetine Hcl	Paroxetine Hcl	22	11
Propranolol Hcl	Propranolol Hcl	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	17
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Ibuprofen	Ibuprofen	18	11
Meclizine Hcl	Meclizine Hcl	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Cephalexin	Cephalexin	17	17
Januvia	Sitagliptin Phosphate	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Acyclovir	Acyclovir	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Betamethasone Valerate	Betamethasone Valerate	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Proair Respiclick	Albuterol Sulfate	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Novolin N	Insulin Nph Human Isophane	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Repatha Syringe	Evolocumab	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error